Is it appropriate to compare the results from two clinical trials with one drug in common?
作者信息
Marrugat Jaume, Vila Joan, Elosua Roberto
机构信息
Grupo de Investigación en Genética y Epidemiología Cardiovascular, Programa de Investigación en Procesos Inflamatorios y Cardiovasculares, IMIM-Hospital del Mar, Barcelona, Spain.
Grupo de Investigación en Genética y Epidemiología Cardiovascular, Programa de Investigación en Procesos Inflamatorios y Cardiovasculares, IMIM-Hospital del Mar, Barcelona, Spain.
出版信息
Rev Esp Cardiol (Engl Ed). 2013 Feb;66(2):151-3. doi: 10.1016/j.rec.2012.06.014. Epub 2012 Sep 14.
PMID:24775396
Abstract
摘要
相似文献
1
Is it appropriate to compare the results from two clinical trials with one drug in common?比较两项使用同一种药物的临床试验结果是否合适？
Rev Esp Cardiol (Engl Ed). 2013 Feb;66(2):151-3. doi: 10.1016/j.rec.2012.06.014. Epub 2012 Sep 14.
2
Evaluation of comparative treatment effects using indirect comparisons.使用间接比较评估对比治疗效果。
Rev Esp Cardiol (Engl Ed). 2013 Feb;66(2):156-7. doi: 10.1016/j.rec.2012.09.013. Epub 2012 Dec 14.
3
Evaluation of comparative treatment effects using indirect comparisons. Response.
Rev Esp Cardiol (Engl Ed). 2013 Feb;66(2):157. doi: 10.1016/j.rec.2012.10.002. Epub 2012 Dec 21.
4
[Using ADP receptor antagonists in coronary heart disease and acute coronary syndrome].[在冠心病和急性冠脉综合征中使用ADP受体拮抗剂]
Praxis (Bern 1994). 2014 Sep 3;103(18):1049-58. doi: 10.1024/1661-8157/a001762.
5
[Letter to Kardiologia Polska concerning optimal treatment of myocardial infarction].[致《波兰心脏病学》关于心肌梗死最佳治疗的信]
Kardiol Pol. 2012;70(2):213-4.
6
New antiplatelet agents in the treatment of acute coronary syndromes.新型抗血小板药物治疗急性冠脉综合征。
Arch Cardiovasc Dis. 2014 Mar;107(3):178-87. doi: 10.1016/j.acvd.2014.01.009. Epub 2014 Mar 11.
7
[Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].[普拉格雷用于急性冠状动脉综合征患者的急性和长期治疗：当前的最佳治疗方法是什么？]
Dtsch Med Wochenschr. 2011 Apr;136(15):782-5. doi: 10.1055/s-0031-1272567. Epub 2011 Mar 22.
8
Controversies in acute cardiovascular care.急性心血管护理中的争议
Eur Heart J. 2014 Mar;35(9):535.
9
10
Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: the POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study.
Int J Cardiol. 2013 Oct 12;168(5):5004-5. doi: 10.1016/j.ijcard.2013.07.121. Epub 2013 Jul 31.
Zotero 插件